The fear was real. The lockdowns were real. COVID-19 was real. But what did New Zealand's decision-makers actually know about the danger, what evidence supported testing and vaccination policies, and did extraordinary restrictions remain justified as that evidence changed? Six years later, newly released government documents allow New Zealanders to examine the decisions that transformed their lives
Report by eLocal - Part 1 of 3 Part 2 here
The Day Everything Changed
On 23 March 2020, New Zealanders gathered around televisions to hear a message that would transform everyday life. For weeks, frightening pictures had arrived from overseas. Wuhan had been locked down. Italian hospitals appeared overwhelmed. Television screens showed ambulances, intensive-care wards and mounting death tolls.
Prime Minister Jacinda Ardern told the country New Zealand had 102 confirmed COVID-19 cases. "But so did Italy once," she warned. If community transmission took hold, she said cases could double every five days, the health system could be inundated and tens of thousands of New Zealanders could die. New Zealand moved immediately to Alert Level 3 and, within 48 hours, to Level 4. Ardern described the decision as imposing "the most significant restriction on New Zealanders' movements in modern history."
Schools and businesses closed. Travel stopped. Families were separated. Funerals, weddings, worship, education and employment were transformed. Most citizens had no practical means of examining the epidemiological models, hospital projections or laboratory science underlying what they were being told.
Government possessed the information. The public had to trust it.
Behind the television broadcast, however, another story had already begun.
On 16 March 2020, Health Report 20200469 recommended issuing an Epidemic Notice under the Epidemic Preparedness Act 2006. New Zealand had recorded eight confirmed cases as of the previous day. Officials anticipated rapid, potentially exponential growth if overseas patterns were repeated here.
The report recommended making additional statutory powers available before widespread community transmission had taken hold.
Those powers included restricting movement, closing premises, requiring medical examinations and testing, and imposing isolation or quarantine.
The report described the Epidemic Notice as a precautionary measure. It also recorded that officials were not recommending a Civil Defence emergency declaration at that stage.
This was the beginning of a sequence of decisions that would continue for more than two years.
The central question is not simply whether a virus existed or whether officials were justified in responding to it.
It is whether the evidence supporting extraordinary state power was sufficient when that power was introduced, and whether it remained sufficient as the scientific and epidemiological picture changed.
The Risk Was Never Equal
One of the most important facts in the contemporary record was already visible in March 2020: officials understood that the danger was not evenly distributed.
Ministry-commissioned modelling dated 16 March examined the potential age-specific health effects of uncontrolled spread. The report was based on assumptions drawn from the limited international evidence then available and explicitly acknowledged substantial uncertainty. The Ministry subsequently classified it as earlier draft modelling superseded by later work.
The 16 March age-specific model used an assumption that 0.25 percent of symptomatic patients would die from the disease, an estimate the authors said had been supplied by the New Zealand Ministry of Health.
A subsequent model used a 0.3 percent infection fatality risk, which the researchers converted to a 0.45 percent case fatality risk on the assumption that 67 percent of infections would become symptomatic.
These were modelling assumptions, not subsequently observed New Zealand mortality rates.
They also cannot be read in isolation from the models' other assumptions concerning transmission, hospitalisation, intensive-care capacity and the potential consequences of widespread infection.
Even a relatively small population-wide fatality percentage could translate into a substantial number of deaths if a large proportion of the population became infected. The distribution of risk also mattered, with older and medically vulnerable New Zealanders facing substantially greater danger.
The question for government was therefore not simply how many people might die. It was how to protect those at greatest risk while weighing the wider consequences of restrictions imposed on the entire population.
That distinction becomes increasingly important when examining decisions made after the initial emergency.
What Did the Government Actually Have Before It?
The Ministry of Health OIA material provides a more detailed picture of the government's documentary decision-making.
On 5 August 2026, Tracy Lynch requested the original written recommendation supporting the Epidemic Notice, together with its attachments, underlying evidence, modelling and advice.
The request also sought the corresponding material for every subsequent renewal, including the dates on which evidence became available and whether it was before decision-makers when their decisions were made.
On 18 September 2026, the Ministry responded under reference H2026086129.
The Ministry supplied the original recommendation and ten subsequent recommendations, with some information withheld under the Official Information Act.
The released records establish that the statutory recommendations were made and that officials recorded their reasons for recommending the use or continuation of emergency powers.
But a recommendation is not the same thing as the complete scientific record underpinning it.
Health Report 20200469 records the Director-General's assessment that an outbreak was likely to significantly disrupt essential governmental and business activity.
It refers to the World Health Organization's characterisation of COVID-19 as a pandemic, the rapidly developing international situation and the potential for exponential growth in New Zealand.
The statutory test, however, was not simply whether the WHO had described the outbreak as a pandemic.
Under section 5 of the Epidemic Preparedness Act 2006, the Prime Minister, with the agreement of the Minister of Health and after considering the Director-General's written recommendation, had to be satisfied that the effects of an outbreak of a quarantinable disease were likely to significantly disrupt essential governmental and business activity.
The Act permitted an Epidemic Notice where the relevant outbreak was occurring overseas, even before widespread transmission occurred in New Zealand.
That distinction matters because the existence of only eight confirmed New Zealand cases did not, by itself, prevent the statutory threshold from being met.
The question is what evidence supported the assessment of likely significant disruption.
What modelling was available? What assumptions were made about hospital capacity, transmission and mortality? What uncertainty was communicated? Which alternative scenarios were examined?
And which of those materials were actually before the decision-makers when the recommendation was accepted?
The OIA package provides a documented starting point for answering those questions. It does not yet establish a complete independent verification chain for every material factual premise.
That is an evidential question requiring further investigation, not proof that the original decision was unlawful.
When Cases Came to Rule Daily Life
Every day New Zealand waited for another number. Cases. Zero cases. Four cases. Twenty cases. Community cases. Border cases. A handful of positive results could dominate the national news and influence decisions affecting millions.
But beneath that apparently simple number was a more complicated question: what exactly did a positive test establish?
At the centre of the testing system was PCR, the polymerase chain reaction. Dr Kary Mullis received half of the 1993 Nobel Prize in Chemistry for developing PCR, a technique capable of amplifying tiny quantities of selected genetic material until they can be detected and analysed.
Mullis died in August 2019, before SARS-CoV-2 emerged, so claims that he specifically condemned COVID PCR testing cannot be correct.
What he did leave behind was a principle relevant to scientific investigation.
Discussing an entirely different scientific controversy, Mullis recalled searching for the scientific literature supporting a proposition he had been expected to accept.
"All I wanted was where are the papers?"
Later he put the principle even more simply:
"That's what science is supposed to do. It's empirical science."
The distinction between scientific detection and the conclusions drawn from it would become a central question in New Zealand's COVID response.
Professor Wakeling Asks for Proof
By June 2021, Professor Robin Wakeling was asking similar questions in New Zealand.
Professor Wakeling is a microbiologist and biodeterioration expert with a PhD in fungal ecology from the University of Waikato. He spent 25 years as a research scientist at the New Zealand Forest Research Institute before establishing a private consultancy specialising in microbial building forensics.
PCR was not something Professor Wakeling encountered for the first time during COVID.
In his 2021 eLocal article, he described helping establish and supervise government-funded PCR research between 2001 and 2005 to identify difficult-to-detect fungi in buildings, before subsequently applying molecular techniques in commercial forensic investigation.
His concern centred on the distinction between what PCR could detect and what could legitimately be concluded from that detection.
Professor Wakeling wrote that PCR's extraordinary sensitivity, combined with the difficulty of establishing a reliable diagnostic relationship between a small amount of detected pathogen material and actual disease, created "enormous room for error."
His wider conclusions about COVID policy require their own evidential examination. Experience with PCR in fungal research does not, by itself, establish the clinical performance of particular SARS-CoV-2 diagnostic assays.
But his central question was specific and testable.
Detection of viral genetic material, current infection, infectiousness, symptomatic disease and serious illness are related concepts, but they are not identical.
Professor Wakeling said he had asked "the highest levels of our Government for proof of concept for their Covid19 policies in clear scientific terms."
That was June 2021, while the response was still operating.
His challenge was straightforward: show us the evidence.
Five Years Later, the OIA Asks Again
The OIA returns directly to the testing question.
The request sought final clinical evidence, validation material and risk assessments concerning PCR, LAMP and antigen testing, together with evidence relating to nasal, nasopharyngeal and oropharyngeal sampling.
It also sought advice concerning informed consent, bodily integrity, the right to refuse medical treatment, available alternative specimens, contraindications, training and adverse-event reporting.
The Ministry's response directed the requester to publicly available information concerning revoked COVID-19 orders and supplied Health Report 20201430, dated 14 August 2020.
That report concerned an order requiring testing for specified workers in managed isolation and quarantine facilities and at the Auckland and Tauranga ports.
The report stated that compulsory testing was necessary to establish whether workers had contracted COVID-19, determine transmission risk and support treatment and contact tracing.
It also recorded the relevant consultation requirements and the Director-General's advice concerning the risk of outbreak or spread.
The proposed order required specified workers to report for and submit to medical examination and testing, subject to appropriate clinical exemptions.
Here the distinction is crucial.
Demonstrating that government had a public-health and legal justification for compulsory testing is not necessarily the same thing as producing the laboratory validation underpinning the testing method.
Health Report 20201430 primarily records the policy and legal justification for requiring testing.
It does not itself reproduce the complete clinical validation material requested under the OIA.
Nor does the released report reproduce every underlying item of scientific advice to which it refers.
That does not establish that PCR testing was never validated. It does not demonstrate that no clinical validation existed elsewhere or that the tests were incapable of identifying SARS-CoV-2 infection.
It establishes a narrower documentary question.
Where is the validation material that supported the specific testing methods when compulsory testing was authorised?
What validation was performed? What did it establish? What were its limitations? How was a positive result interpreted? What did officials understand about the relationship between detection and infectiousness?
What safety and clinical evidence supported the particular sampling methods used?
And what assessment was undertaken of the right to refuse medical treatment when testing became compulsory for specified workers?
Professor Wakeling was asking questions about the scientific foundation of testing in 2021.
In 2026, the OIA has produced part of the documentary trail.
The next step is to identify the underlying laboratory and clinical records, rather than treating a policy briefing as a substitute for the complete scientific evidence.
Part 1 ends here. The next part begins with “Then Vaccination Changed the Equation” and continues through the vaccination requirements, employment consequences and healthcare complaints.